Doxorubicin News and Research

RSS
Doxorubicin hydrochloride is approved for use with other drugs as adjuvant therapy for breast cancer that has spread to the lymph nodes, including cancer that is HER-2 positive or has spread after surgery.

In addition to the uses that have been approved by the FDA, doxorubicin hydrochloride is sometimes used alone or with other drugs to treat other types of cancer. The drug continues to be studied in the treatment of many types of cancer.
IBN’s green tea-based drug nanocarriers show superior tumor-killing performance

IBN’s green tea-based drug nanocarriers show superior tumor-killing performance

Machine learning can help accurately predict clinical outcomes in patients with heart problems

Machine learning can help accurately predict clinical outcomes in patients with heart problems

Breast cancer and lymphoma survivors at greater risk of developing heart failure

Breast cancer and lymphoma survivors at greater risk of developing heart failure

Breast cancer patients may be at increased risk of cardiovascular diseases

Breast cancer patients may be at increased risk of cardiovascular diseases

Scientists find sperm as potential drug carrier to treat gynecological conditions

Scientists find sperm as potential drug carrier to treat gynecological conditions

New cancer drug begins clinical trial in human patients with rare brain tumor

New cancer drug begins clinical trial in human patients with rare brain tumor

Researchers propose new treatment strategy for colon cancer patients

Researchers propose new treatment strategy for colon cancer patients

Injecting plant-based nanoparticles and chemotherapy drug helps halt tumor progression in mice

Injecting plant-based nanoparticles and chemotherapy drug helps halt tumor progression in mice

New cancer drug shows promise to treat leukemia in mouse models

New cancer drug shows promise to treat leukemia in mouse models

Immunotherapy combination offers new hope for women with early stage triple negative breast cancer

Immunotherapy combination offers new hope for women with early stage triple negative breast cancer

Men appear to have worse chemotherapy-induced cardiomyopathy than women, research shows

Men appear to have worse chemotherapy-induced cardiomyopathy than women, research shows

WSU scientists develop new approach to deliver therapeutics to tumors

WSU scientists develop new approach to deliver therapeutics to tumors

Study finds no clear benefit of stem-cell transplant for double-hit lymphoma patients in remission

Study finds no clear benefit of stem-cell transplant for double-hit lymphoma patients in remission

UAB symposium highlights use of tissue engineering to repair broken hearts

UAB symposium highlights use of tissue engineering to repair broken hearts

Short-term fasting during chemotherapy may counteract side effects of common cancer drugs

Short-term fasting during chemotherapy may counteract side effects of common cancer drugs

UAB chemists design microcapsules for guided drug delivery system to target solid tumors

UAB chemists design microcapsules for guided drug delivery system to target solid tumors

Metabolic vulnerability in triple-negative breast cancer cells may help quell chemotherapy resistance

Metabolic vulnerability in triple-negative breast cancer cells may help quell chemotherapy resistance

New project aims to improve efficiency of cytostatic drugs used in cancer treatment

New project aims to improve efficiency of cytostatic drugs used in cancer treatment

Timing of chemotherapy can have big effect on inflammation, study shows

Timing of chemotherapy can have big effect on inflammation, study shows

Chemotherapy-induced senescent cells promote side effects and cancer relapse

Chemotherapy-induced senescent cells promote side effects and cancer relapse